A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence the progression of neurodegeneration remains something of a black box ...

Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...

A nonprofit assisting dementia patients and their families gave out free memory screenings in southeast Grand Rapids Thursday ...

Alzheimer's researchers are widening the scope of biomarkers used to detect Alzheimer's and dementia. In a recent research update, the Alzheimer's Association a ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.

Without a patient having to wait to see a specialist, the robot can run approximately 3.9 million tests per year on a ...

Researchers map the unique genetic regulation of proteins in human cerebrospinal fluid, identifying potential targets for ...

The health, physical activity and eating habits of 1,516 participants over-65s were monitored by a team of scientists in ...

In a promising development for Alzheimer’s disease diagnostics, Veravas, Inc. and Phanes Biotech have announced their ...

Older people whose cholesterol readings show big changes from one year to the next may be at an increased risk of cognitive problems as they age, including dementia.

We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this debilitating disease.

Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.